EGRX insider trading

CIK 827871

EAGLE PHARMACEUTICALS, INC.: insider trade history from SEC Form 4 filings.

Form 4 trades
302
Last 90 days
0
Buys / sells
4% / 57%
Insiders
20

EGRX insider activity at a glance

FilingIQ tracks 302 insider transactions for EGRX in filings since May 7, 2015. The most recent transaction is dated Feb 28, 2024. They were reported by 20 insiders.

Across the full history, 12 open-market purchases and 172 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

How FilingIQ classifies each line, and the seven facts it shows on every open-market purchase and sale, are documented on the methodology page.

Latest EGRX Form 4 filings

Most recent disclosures. Sign up to filter by transaction code, insider role or dollar value.

Tickers with similar insider activity

Ranked next to EGRX by Form 4 lines in the last 90 days, the number on each card.

13F funds holding EGRX

For the quarter ended Sep 30, 2026, 2 institutional managers reported a EGRX position on SEC Form 13F.

Frequently asked

How many insider trades does FilingIQ track for EGRX?
FilingIQ tracks 302 Form 4 insider transactions for EGRX (EAGLE PHARMACEUTICALS, INC.), covering filings from May 7, 2015 onwards. 0 of those are dated within the last 90 days.
Are EGRX insiders net buyers or net sellers?
Across the full Form 4 history for EGRX, 12 transactions (4%) were open-market purchases and 172 (57%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does EGRX insider data come from?
Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ links every filing to the insider's SEC CIK, marks plan trades, tax withholding, option exercises, gifts, derivatives and amendments, and shows each open-market purchase and sale with the same fixed facts. It does not rate the stock.
How many institutions report holding EGRX?
For the quarter ended Sep 30, 2026, 2 institutional managers reported a EGRX position on SEC Form 13F. Investment managers with discretion over $100 million or more in 13(f) securities, mostly US-listed stocks, file a Form 13F within 45 days of each quarter end.

Methodology & sources

Every EGRX insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Institutional holder counts come from the quarter's SEC Form 13F reports. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). How lines are classified and which facts FilingIQ adds is documented on the methodology page; the people behind it are on the team page. Not investment advice; see disclaimer.